- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
2142
HKG
Week ended 07 Aug 2026
Weekly Investor Report
HBM Holdings Limited · Healthcare · Biotechnology
Latest close
14.19 HKD
16.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 15.1% above the Trend Line and sits at 54.0% of its 52-week range. The latest completed week returned 16.5%, after a 21.8% four-week move. The latest news-sentiment score is 50/100.
Setup score
57
out of 100
Latest Close
14.19 HKD
7 Aug 2026
1W Return
16.5%
latest completed week
4W Return
21.8%
short-term follow-through
12W Return
10.8%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
16.5%
Latest completed week; four-week move 21.8%.
Indicator stack
28/58
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 15.1% above the Trend Line and sits at 54.0% of its 52-week range. The latest completed week returned 16.5%, after a 21.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2912-week average 0.42
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.29Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 21.8% over four weeks, 10.8% over 12 weeks, and 36.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.01Latest activity-pressure read.
Pressure change99.2%Four-week change in activity pressure.
Leadership9.82Latest relative-leadership reading.
RS change486.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.1%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+16.5%Week of 7 Aug.
Worst week-9.3%Week of 5 Jun.
Latest week+16.5%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains2
Flat weeks0
Modest losses9
Sharp losses6
Recent vol8.0%13-week weekly-return volatility.
Base vol8.2%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew9.1% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank7 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Biotechnology
4-week rank5 / 77
Group average2.4%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD24.7%positive activity pressure
RS20.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 2/12.
Activity pressure 0.29; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 14.19 HKD | 16.5% | 12.33 HKD | 6.42 HKD | -0.01 | 9.82 | 16.6M | Off |
| 31 Jul 2026 | 12.18 HKD | -2.6% | 12.32 HKD | 6.34 HKD | -0.44 | -6.04 | 13.6M | Off |
| 24 Jul 2026 | 12.51 HKD | 8.7% | 12.32 HKD | 6.28 HKD | -0.66 | 0.46 | 15.1M | Off |
| 17 Jul 2026 | 11.51 HKD | -1.2% | 12.33 HKD | 6.21 HKD | -0.94 | -5.62 | 14.5M | Off |
| 10 Jul 2026 | 11.65 HKD | 2.4% | 12.39 HKD | 6.14 HKD | -0.94 | -2.54 | 15.8M | Off |
| 3 Jul 2026 | 11.38 HKD | 13.1% | 12.45 HKD | 6.08 HKD | -1.12 | -0.81 | 4.7M | Off |
| 26 Jun 2026 | 10.06 HKD | -7.7% | 12.55 HKD | 6.02 HKD | -1.20 | -9.21 | 4.8M | Off |
| 19 Jun 2026 | 10.90 HKD | 8.7% | 12.66 HKD | 5.96 HKD | -0.95 | -6.40 | 20.9M | Off |
| 12 Jun 2026 | 10.03 HKD | -5.4% | 12.73 HKD | 5.90 HKD | -0.75 | -16.22 | 3.0M | Off |
| 5 Jun 2026 | 10.60 HKD | -9.3% | 12.86 HKD | 5.85 HKD | -0.28 | -12.17 | 4.4M | Off |
| 29 May 2026 | 11.69 HKD | -3.8% | 12.93 HKD | 5.79 HKD | 0.16 | -3.64 | 22.2M | Off |
| 22 May 2026 | 12.15 HKD | -5.2% | 12.99 HKD | 5.73 HKD | 0.30 | -1.19 | 21.0M | Off |
| 15 May 2026 | 12.81 HKD | -3.0% | 13.00 HKD | 5.66 HKD | 0.38 | 3.16 | 14.7M | On |
| 8 May 2026 | 13.20 HKD | 1.5% | 13.00 HKD | 5.59 HKD | 0.56 | 4.99 | 10.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.